128 related articles for article (PubMed ID: 6229465)
21. Biliary permeability during ethinyl estradiol-induced cholestasis studied by segmented retrograde intrabiliary injections in rats.
Iqbal S; Mills CO; Elias E
J Hepatol; 1985; 1(3):211-9. PubMed ID: 4067253
[TBL] [Abstract][Full Text] [Related]
22. Carrier-mediated electrogenic transport of estradiol-17 beta-glucuronide in rat liver BMV.
Vore M; Hoffman T
Am J Physiol; 1994 Oct; 267(4 Pt 1):G546-51. PubMed ID: 7943320
[TBL] [Abstract][Full Text] [Related]
23. The secretory characteristics of dehydrocholate in the dog: comparison with the natural bile salts.
O'Máille ER; Richards TG
J Physiol; 1976 Oct; 261(2):337-57. PubMed ID: 978576
[TBL] [Abstract][Full Text] [Related]
24. Reversibility of organic anion-induced cholestasis: association with compensatory hypersecretion of biliary phospholipid and protein in the dog.
Tazuma S; Tokumo H; Yamashita G; Horikawa K; Miura H; Hirano N; Aihara N; Sasaki M; Teramen K; Ochi H
J Gastroenterol Hepatol; 1994; 9(1):35-9. PubMed ID: 8155864
[TBL] [Abstract][Full Text] [Related]
25. Altered localization and activity of canalicular Mrp2 in estradiol-17beta-D-glucuronide-induced cholestasis.
Mottino AD; Cao J; Veggi LM; Crocenzi F; Roma MG; Vore M
Hepatology; 2002 Jun; 35(6):1409-19. PubMed ID: 12029626
[TBL] [Abstract][Full Text] [Related]
26. Hepatic uptake and excretion of [14C]sodium taurocholate by the isolated perfused fetal sheep liver.
Ring JA; Ghabrial H; Ching MS; Potocnik S; Shulkes A; Smallwood RA; Morgan DJ
Biochem Pharmacol; 1994 Aug; 48(4):667-74. PubMed ID: 8080439
[TBL] [Abstract][Full Text] [Related]
27. The mutant Eisai hyperbilirubinemic rat is resistant to bile acid-induced cholestasis and cytotoxicity.
Hoshino M; Hayakawa T; Hirano A; Kamiya Y; Ohiwa T; Tanaka A; Kumai T; Inagaki T; Miyaji M; Takeuchi T
Hepatology; 1994 Oct; 20(4 Pt 1):932-9. PubMed ID: 7927235
[TBL] [Abstract][Full Text] [Related]
28. The influence of dehydrocholate on hepatic uptake and biliary excretion of 3H-taurocholate and 3H-ouabain.
Meijer DK; Vonk RJ; Scholtens EJ; Levine WG
Drug Metab Dispos; 1976; 4(1):1-7. PubMed ID: 3395
[TBL] [Abstract][Full Text] [Related]
29. Characterization of cholestasis induced by estradiol-17 beta-D-glucuronide in the rat.
Meyers M; Slikker W; Pascoe G; Vore M
J Pharmacol Exp Ther; 1980 Jul; 214(1):87-93. PubMed ID: 7391975
[TBL] [Abstract][Full Text] [Related]
30. Tauroursodeoxycholate prevents taurocholate induced cholestasis.
Kitani K; Kanai S
Life Sci; 1982 Feb; 30(6):515-23. PubMed ID: 7070216
[TBL] [Abstract][Full Text] [Related]
31. Influence of dehydrocholate and taurocholate on bromsulphthalein uptake, storage, and excretion in the dog.
Delage Y; Erlinger S; Duval M; Bpenhamou JP
Gut; 1975 Feb; 16(2):105-8. PubMed ID: 1126660
[TBL] [Abstract][Full Text] [Related]
32. Enhanced biliary excretion of canalicular membrane enzymes in estrogen-induced and obstructive cholestasis, and effects of different bile acids in the isolated perfused rat liver.
Accatino L; Figueroa C; Pizarro M; Solís N
J Hepatol; 1995 Jun; 22(6):658-70. PubMed ID: 7560859
[TBL] [Abstract][Full Text] [Related]
33. Bile duct obstruction is not a prerequisite for type I biliary epithelial cell hyperplasia.
Kossor DC; Meunier PC; Dulik DM; Leonard TB; Goldstein RS
Toxicol Appl Pharmacol; 1998 Oct; 152(2):327-38. PubMed ID: 9853002
[TBL] [Abstract][Full Text] [Related]
34. Characterization of [3H]estradiol-17 beta-(beta-D-glucuronide) binding sites in basolateral and canalicular liver plasma membranes.
Changchit A; Durham S; Vore M
Biochem Pharmacol; 1990 Sep; 40(6):1219-25. PubMed ID: 2169743
[TBL] [Abstract][Full Text] [Related]
35. Effects of taurocholate infusion on biliary excretion in isolated perfused rat livers. Decreased biliary excretion of dibromosulfophthalein in pregnancy.
Durham S; Mack R; Vore M
Drug Metab Dispos; 1985; 13(6):695-9. PubMed ID: 2867873
[TBL] [Abstract][Full Text] [Related]
36. Glycoursodeoxycholate is as effective as tauroursodeoxycholate in preventing the taurocholate-induced cholestasis in the rat.
Kanai S; Kitani K
Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):423-30. PubMed ID: 6665300
[TBL] [Abstract][Full Text] [Related]
37. Hepatic uptake and biliary excretion of organic cations--I. Characterization of three new model compounds.
Neef C; Keulemans KT; Meijer DK
Biochem Pharmacol; 1984 Dec; 33(24):3977-90. PubMed ID: 6508847
[TBL] [Abstract][Full Text] [Related]
38. Role of extracellular Ca2+ in hepatic bile formation and taurocholate transport.
Anwer MS; Clayton LM
Am J Physiol; 1985 Dec; 249(6 Pt 1):G711-8. PubMed ID: 4083352
[TBL] [Abstract][Full Text] [Related]
39. Interplay of phase II enzymes and transporters in futile cycling: influence of multidrug resistance-associated protein 2-mediated excretion of estradiol 17beta-D-glucuronide and its 3-sulfate metabolite on net sulfation in perfused TR(-) and Wistar rat liver preparations.
Sun H; Zeng YY; Pang KS
Drug Metab Dispos; 2010 May; 38(5):769-80. PubMed ID: 20124397
[TBL] [Abstract][Full Text] [Related]
40. Hepatic pharmacokinetics of taurocholate in the normal and cholestatic rat liver.
Hung DY; Siebert GA; Chang P; Roberts MS
Br J Pharmacol; 2005 May; 145(1):57-65. PubMed ID: 15711588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
